Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer-Reference-Cited by-同舟云学术

Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer

Published:2023-05 Issue:5 Volume:34 Page:477-485
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Chowdhury S.,Bjartell A.,Agarwal N.,Chung B.H.,Given R.W.,Pereira de Santana Gomes A.J.,Merseburger A.S.,Özgüroğlu M.,Juárez Soto Á.,Uemura H.,Ye D.,Brookman-May S.D.,Londhe A.,Bhaumik A.,Mundle S.D.,Larsen J.S.,McCarthy S.A.,Chi K.N.

Funder

Janssen Research and Development LLC

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference27 articles.

1. Targeting metastatic hormone sensitive prostate cancer: chemohormonal therapy and new combinatorial approaches;Damodaran;J Urol,2019

2. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group;Scher;J Clin Oncol,2008

3. Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer;Fizazi;N Engl J Med,2017

4. Abiraterone for prostate cancer not previously treated with hormone therapy;James;N Engl J Med,2017

5. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer: long-term survival analysis of the randomized phase III E3805 CHAARTED trial;Kyriakopoulos;J Clin Oncol,2018

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world Efficacy and Safety of Low-Dose Abiraterone With Food and Standard-Dose Abiraterone in De Novo Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Analysis;Clinical Genitourinary Cancer;2024-12

2. Akkermansia muciniphila Metabolite Inosine Inhibits Castration Resistance in Prostate Cancer;Microorganisms;2024-08-12

3. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II—2024 Update: Treatment of Relapsing and Metastatic Prostate Cancer;European Urology;2024-08

4. Prostate-specific Antigen Nadir and Cancer-Control Outcomes in Real-world Apalutamide-treated Metastatic Hormone-Sensitive Prostate Cancer Patients: A Single-Center Analysis;European Urology Oncology;2024-08

5. Targeted Investigational Treatment Analysis of Novel Anti‐androgen (TITAN) study: ultralow prostate‐specific antigen decline with apalutamide plus androgen‐deprivation therapy;BJU International;2024-06-28